Report of mammary fibroepithelial hyperplasia in a DSH cat

Document Type : Case report

Authors

1 Associate Professor, Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

2 Assistant Professor, Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

3 Professor, Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

4 Resident of small animal internal medicine, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

5 DVM Student, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

Abstract

Fibroepithelial hyperplasia is a physiological change in mammary glands tissue characterized by a significant increase in the size of one or more mammary glands. The disease is commonly seen in healthy cats and may also be seen in older female cats. This report describes the clinical, radiographic, and microscopic features of a cat with fibroepithelial hyperplasia. A 4-year-old female cat weighing 2.7 kg with a large mass below the abdomen was referred to the veterinary hospital of Shahid Chamran University of Ahvaz. After clinical examination and radiological evaluation, he underwent surgery and the isolated mass was sent to the pathology department. The mass was solid and was observed at the incision of several lobules that had a walnut-like appearance. Under microscopic examination, proliferation of mammary duct epithelial cells and formation of new tubules were significant. Also, a large amount of connective tissue was observed around the formed tubes. Empty spaces were observed between the connecting strands, which indicated edema. It should be noted that no malignant changes were observed. In general, according to clinical, radiological and microscopic characteristics, fibroepithelial hyperplasia was diagnosed. The pathophysiology of fibroepithelial hyperplasia of the mammary gland is not well understood, but most likely sexual hormones play roles in etiology of fibroepithelial hyperplasia.

Keywords

References

Burstyn, U. (2010). Management of mastitis and abscessation of mammary glands secondary to fibroadenomatous hyperplasia in a primiparturient cat. Journal of the American Veterinary Medical Association, 236(3), 326-329.‏
Giménez, F., Hecht, S., Craig, L. E., & Legendre, A. M. (2010). Early detection, aggressive therapy: optimizing the management of feline mammary masses. Journal of Feline Medicine and Surgery, 12(3), 214-224.‏
Hayden, D. W., Johnston, S. D., Kiang, D. T., Johnson, K. H., & Barnes, D. M. (1981). Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. American Journal of Veterinary Research, 42(10), 1699.‏
Hayes, A. A., & Mooney, S. (1985). Feline mammary tumors. Veterinary Clinics of North America: Small Animal Practice, 15(3), 513-520.‏
Leidinger, E., Hooijberg, E., Sick, K., Reinelt, B., & Kirtz, G. (2011). Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features. Tierarztl Prax Ausg K Kleintiere Heimtiere, 39(3), 198-202.
MacDougall, L. D. (2003). Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. The Canadian Veterinary Journal, 44(3), 227.‏
Millanta, F. A., Calandrella, M., Bari, G., Niccolini, M., Vannozzi, I, & Poli, A. L. E. S. S. A. N. D. R. O. (2005). Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science, 79(3), 225-232.‏
Payan-Carreira, R. (2013). Feline mammary fibroepithelial hyperplasia: a clinical approach. Insights from Veterinary Medicine. InTechOpen, 215-232.‏
Pereira, P. D., Carvalheira, J., & Gärtner, F. (2004). Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue–an immunohistochemical study. The Veterinary Journal, 168(2), 180-185.‏
Wehrend, A., Hospes, R., & Gruber, A. D. (2001). Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist,‏ 148(11), 346-7.

Files

Share

How to cite

Statistics